InvestorsHub Logo
Followers 17
Posts 4048
Boards Moderated 0
Alias Born 01/12/2004

Re: chmcnfunds post# 67

Tuesday, 08/01/2017 9:49:24 AM

Tuesday, August 01, 2017 9:49:24 AM

Post# of 190
$20 in a year or two. Should easily be $10+ when Cotempla hits the market. I'm looking forward to the next release of Adzenys numbers.
How come "Hydrocodone polistirex and chlorpheniramine polistirex extended-release (XR) liquid suspension" is listed under Products Overview and not Pipeline? Is it approved? That's a huge one if it is abuse deterrent.
NEOS doesn't have a unique business model, but they appear to be executing well and have a lot of opportunity.